Cyclo (RGDyC)

• Description :

  Cyclo (RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo (RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2].

• CAS Number :

  [1206475-79-7]

• UNSPSC :

  12352209

• Target :

  Biochemical Assay Reagents

• Type :

  Peptides

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cyclo-rgdyc.html

• Purity :

  98.29

• Solubility :

  DMSO : 83.33 mg/mL (ultrasonic)

• Smiles :

  O=C([C@@H](NC(CNC([C@@H](NC([C@@H](NC1=O)CS)=O)CCCNC(N)=N)=O)=O)CC(O)=O)N[C@@H]1CC2=CC=C(C=C2)O

• Molecular Formula :

  C24H34N8O8S

• Molecular Weight :

  594.64

• References & Citations :

  [1]Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24 (13) :135101.|[2]Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90 (13) :8188-8195.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported